Ptc Therapeutics (PTCT) Shares Outstanding (2012 - 2026)
Ptc Therapeutics (PTCT) posted quarterly Shares Outstanding (Entity) of $83.3 million for Q2 2026, up 4.98% year-over-year from $79.4 million in Q2 2025, and up 0.54% quarter-over-quarter from $82.9 million in Q1 2026.
Ptc Therapeutics (PTCT) Shares Outstanding (2012 - 2026) Analysis & Trends
Ptc Therapeutics' Shares Outstanding (Entity) history runs 15 years deep, the most recent figure standing at $83.3 million for Q2 2026.
- In Q2 2026, Shares Outstanding (Entity) rose 4.98% year-over-year to $83.3 million; the TTM figure through Jun 2026 stood at $83.3 million (up 4.98% YoY), while the FY2025 annual figure was $81.5 million, up 4.85% from the prior year.
- Shares Outstanding (Entity) for Q2 2026 stood at $83.3 million, up from $82.9 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $83.3 million in Q2 2026, with the low at $71.3 million in Q1 2022.
- The 5-year median for Shares Outstanding (Entity) is $76.8 million (2024), against an average of $76.8 million.
- The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Entity) advanced 1.32% in 2022, then grew 5.33% in 2023.
- Ptc Therapeutics' Shares Outstanding (Entity) stood at $73.1 million in 2022, then increased by 3.56% to $75.7 million in 2023, then climbed by 2.64% to $77.7 million in 2024, then grew by 4.85% to $81.5 million in 2025, then increased by 2.27% to $83.3 million in 2026.
- Business Quant data shows PTCT's Shares Outstanding (Entity) at $83.3 million in Q2 2026, $82.9 million in Q1 2026, and $81.5 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 62.19 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 210.89 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.45 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 25.05 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 445.06 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 133.61 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Ptc Therapeutics | 5.97 Bn | 3.75 Bn | 340.60 Mn | 83.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 83.01 Mn |
| Mar 31, 2026 | 82.52 Mn |
| Dec 31, 2025 | 79.53 Mn |
| Sep 30, 2025 | 78.47 Mn |
| Jun 30, 2025 | 78.15 Mn |
| Mar 31, 2025 | 78.12 Mn |
| Dec 31, 2024 | 76.85 Mn |
| Sep 30, 2024 | 76.93 Mn |
| Jun 30, 2024 | 76.73 Mn |
| Mar 31, 2024 | 76.50 Mn |
| Dec 31, 2023 | 74.84 Mn |
| Sep 30, 2023 | 75.38 Mn |
| Jun 30, 2023 | 74.73 Mn |
| Mar 31, 2023 | 73.73 Mn |
| Dec 31, 2022 | 71.73 Mn |
| Sep 30, 2022 | 71.65 Mn |
| Jun 30, 2022 | 71.37 Mn |
| Mar 31, 2022 | 71.22 Mn |
| Dec 31, 2021 | 70.47 Mn |
| Sep 30, 2021 | 70.59 Mn |